Synthesis, Biological Evaluation and Molecular Docking Studies of New 4‐(Cyanomethyl)‐ N' ‐Substituted Benzohydrazide Derivatives as Anti‐Alzheimer Agents
Drug Development Research · 2025
DOI: 10.1002/ddr.70166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, 2025. Verfasst von Fatih Tok und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Alzheimer Disease, Antioxidants, Hydrazines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Themen: Demenz
Abstract (Originalsprache)
Although the incidence of Alzheimer's disease increases with age, the number of effective drugs in the fight against this disease remains insufficient. In this regard, a new series of hydrazide‐hydrazone derivative compounds ( 3a ‐ 3n ) was synthesized and their structures were elucidated using spectral techniques. Then, all compounds were tested for their in vitro antioxidant and anticholinesterase activities. Compound 3i was found to have the highest antioxidant activity in the series with 63.750 ± 0.033 µM and 44.210 ± 0.058 µM SC 50 values in the DPPH and ABTS methods, respectively. Compound 3i exhibited significantly higher inhibitory properties than the reference standard donepezil with IC 50 values of 1.850 ± 0.013 µM and 3.680 ± 0.034 µM against AChE and BChE enzymes, respectively. The cytotoxicity and AChE inhibition potential of the compounds on the SH‐SY5Y cell line were also evaluated. Compounds 3i and 3l were found to have the highest AChE inhibition (81.03 ± 2.05% and 83.84 ± 2.46%) in SH‐SY5Y cells, respectively. Compound 3l also maintained cell viability at 100 µM concentration. The most active compounds in the series were investigated as competitive or noncompetitive inhibitors against AChE and BChE by enzyme kinetic studies. Moreover, molecular docking and MD simulation studies were used to describe the enzyme‐ligand interactions and their stability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, Istanbul, Turkey.
- Department of Chemistry, Faculty of Arts and Sciences, Recep Tayyip Erdoğan University, Rize, Turkey.
- Department of Biochemistry, School of Medicine, Aydın Adnan Menderes University, Aydın, Turkey.
- Department of Molecular Biotechnology, Institute of Health Sciences, Aydın Adnan Menderes University, Aydın, Turkey.
- Department of Biostatistics and Medical Informatics, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
- Department of Bioinformatics, Institute of Health Sciences, Karadeniz Technical University, Trabzon, Turkey.
ORCID-Profile: Fatih Tok, Gizem Tatar-Yılmaz
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Tok, F., Baltaş, N., Abas, B. İ., Kozan, B., Kaya, S., Tatar-Yılmaz, G., & Çevik, Ö. (2025). Synthesis, Biological Evaluation and Molecular Docking Studies of New 4‐(Cyanomethyl)‐ N' ‐Substituted Benzohydrazide Derivatives as Anti‐Alzheimer Agents. Drug Development Research. https://doi.org/10.1002/ddr.70166
Vancouver
Tok F, Baltaş N, Abas Bİ, Kozan B, Kaya S, Tatar-Yılmaz G, et al. Synthesis, Biological Evaluation and Molecular Docking Studies of New 4‐(Cyanomethyl)‐ N' ‐Substituted Benzohydrazide Derivatives as Anti‐Alzheimer Agents. Drug Development Research. 2025. doi:10.1002/ddr.70166
BibTeX
@article{Tok2025,
author = {Tok, Fatih and Baltaş, Nimet and Abas, Burçin İrem and Kozan, Bensu and Kaya, Süleyman and Tatar-Yılmaz, Gizem and Çevik, Özge},
title = {Synthesis, Biological Evaluation and Molecular Docking Studies of New 4‐(Cyanomethyl)‐ N' ‐Substituted Benzohydrazide Derivatives as Anti‐Alzheimer Agents},
journal = {Drug Development Research},
year = {2025},
doi = {10.1002/ddr.70166}
}
EUVIMED